We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current NEXI market cap is 5.48M. The company's latest EPS is USD -23.1911 and P/E is -0.17.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.79M | -10M | -5.37M | -2.76M | -3.51M |
| Net Income | -7.57M | -9.85M | -5.36M | -3.08M | -2.33M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -20.89M | -27.85M | -53.26M | -63.08M | -32.97M |
| Net Income | -23.21M | -33.15M | -51.28M | -62.51M | -32.34M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 23.47M | 14.56M | 8.59M | 8.99M | 5.86M |
| Total Liabilities | 6.47M | 6.31M | 5.08M | 6.02M | 4.94M |
| Total Equity | 17M | 8.25M | 3.51M | 2.74M | 696k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 13.72M | 11.3M | 91.03M | 43.06M | 8.59M |
| Total Liabilities | 3.11M | 27.06M | 7.27M | 10.76M | 5.08M |
| Total Equity | -43.01M | -69.38M | 83.76M | 32.3M | 3.51M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -18.31M | -25.6M | -31.43M | -2.42M | -4.49M |
| Investing | -48k | -45k | -45k | 523k | 566k |
| Financing | N/A | N/A | N/A | 3.14M | 3.14M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -19.42M | -26.4M | -45.79M | -51.19M | -31.43M |
| Investing | 9.42M | 222k | -53.81M | 50.32M | -45k |
| Financing | 18.77M | 22.09M | 124.89M | 5.18M | N/A |
| Market Cap | 5.48M |
| Price to Earnings Ratio | -0.17 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.71 |
| Price to Book Ratio | 1.56 |
| Dividend Yield | - |
| Shares Outstanding | 1.39M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.05 (1.42%) |
| Company Name | NexImmune Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.neximmune.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
